Insights & Webinars
Insights & Webinars
Focus on Free Cash Flow Over Big Tech Earnings With TTAC
Stocks tumbled on Monday as investors wait to see how several big tech firms fared for the final quarter of 2022. This week, Facebook parent Meta Platforms, Apple, Amazon, and Google parent Alphabet are set to report their quarterly earnings. Considering that stocks al...
TTAC Underweight Big Tech as it Follows the Free Cash Flow
Big tech had a rough 2022. While the S&P 500 ended the year down 20%, the tech-heavy Nasdaq Composite dropped 34%, while tech giants like Microsoft, Google parent Alphabet, and Amazon saw their stock prices fall 28%, 39%, and 51% for the year, respectively. In a webina...
Consider DFRA as Confidence in Housing Market Rises
While mortgage rates are double what they were a year ago, home prices have been falling since June, slightly boosting consumer confidence in the housing market. Fannie Mae’s Home Purchase Sentiment Index increased 3.7 points in December, slightly above its all-time low s...
Under the Hood of TTAC
Free cash flow is the cash generated by a company through its operations after accounting for capital expenditure on fixed assets. FCF Advisors has been focused on free cash flow investment strategies since 2011 and specializes in multi-factor fundamental analysis g...
Apple’s Free Cash Flow Represents Potential Tailwind For DFNV
Despite Apple’s stock dropping 25% year-to-date — lower than the S&P 500’s 19% decline — Brian Sozzi at Yahoo! Finance reported that one analyst argues that will change in 2023. Citi tech analyst Jim Suva is bullish on the stock, believing that demand for the tech...
Apple and Alphabet Implement Massive Share Buyback Programs
While tech giants like Apple (NASDAQ: AAPL) and Google parent Alphabet (NASDAQ: GOOGL) have seen their stocks go down by 27% and 39% year-to-date, both companies have used their ample free cash flow to finance their stock repurchasing programs. Free cash fl...
How Amgen Buying Horizon Therapeutics Could Impact TTAC
Amgen has agreed to buy Horizon Therapeutics in a deal valued at $27.8 billion. The Thousand Oak, California-based biopharmaceutical company announced on Monday that it will pay $116.50 in cash for each share of Horizon. Based in Dublin, Horizon develops potential ...
Target Firms With Strong Free Cash Flow Before a Recession Hits
While the Federal Reserve just raised interest rates by 50 basis points following an upbeat inflation report, many still believe that a recession is nigh — if not already upon us. Economists polled by Reuters expect the U.S. economy to head into a “short and shallow r...
Maintain Core Equity Exposure Amid High Volatility With TTAC
Core equity markets have been volatile this year, with the S&P 500 down nearly 18% year-to-date. To make matters worse, many industry observers believe that stocks may face a recession within the next six to 12 months. Regardless, it’s important that investors mai...
Turn to Real Assets While Inflation Persists
With the S&P 500 down roughly 16% year-to-date and high inflation persisting, more investors are turning to real assets to generate returns for their portfolios. The equity securities of companies connected to real estate, infrastructure, commodities, and natural ...
Contact us